Mineralized fiber network composite bone repair aerogel material with early-stage anti-inflammatory and multiple osteogenesis promoting functions and preparation method of mineralized fiber network composite bone repair aerogel material
The mineralized fiber network composite bone repair aerogel prepared by processes such as wet spinning and plasma activation solves the problem of single function of bone repair materials, and achieves synergistic effects of early anti-inflammatory and multiple bone function promotion, promoting vascularization and neuralization in the bone regeneration process.
Patent Information
- Application Number
- CN202511791164.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-01
- Publication Date
- 2026-03-10
AI Technical Summary
Existing bone repair materials have limited functionality and are unable to synergistically address the complex biological events in bone regeneration, especially the lack of early inflammatory response control and multiple, temporal bone-promoting capabilities.
Chitosan fibers were prepared by wet spinning, and the fibers were twisted to form fiber bundles and woven into a network. A Zn2+-doped hydroxyapatite coating was formed by plasma activation and hydrothermal method. Thioctic acid molecules were grafted onto the surface, and angiogenic drugs were introduced into the gel to form a multi-level mineralized fiber network composite bone repair aerogel.
It achieves early anti-inflammatory function, promotes vascularization and neurotransmission, provides multiple, time-sequential bioactivities, ensures the coordination of mechanical properties and bioactivity during bone repair, and optimizes the repair microenvironment.
Smart Images

Figure CN121622991A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The present application belongs to the technical field of multifunctional bone repair materials, and relates to a bone repair aerogel material and a preparation method thereof, in particular to a mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple osteogenesis functions and a preparation method thereof. BACKGROUND
[0002] The clinical repair of large segment bone defects is a severe challenge in the field of orthopedics. Autologous bone grafting has limited sources and is accompanied by secondary damage, while allogeneic bone grafting has the risk of immune rejection. Therefore, the development of high-performance artificial bone repair materials is urgently needed. However, the existing materials generally have the problem of single function, which is difficult to coordinate the complex biological events in the bone regeneration process, among which two major bottlenecks are particularly prominent: First, the control problem of excessive early inflammatory response. The implanted material as a foreign body often causes a severe inflammatory response in the host, leading to excessive accumulation of reactive oxygen species (ROS) and pro-inflammatory factors, which not only directly damages the surrounding tissue and hinders the migration of repair cells to the defect site, but also seriously inhibits the activity of osteoblasts, and even leads to early failure of the implant. Therefore, giving bone repair materials an active anti-inflammatory ability is a prerequisite for successful regeneration.
[0003] Second, the lack of multiple and time-dependent osteogenesis ability. Successful bone regeneration not only depends on the differentiation of osteoblasts, but also depends on the rapid establishment of new blood vessel networks (vascularization) and appropriate nerve innervation (neuralization) in the early stage, which is a complex process of multiple stages and multiple factors. Traditional materials either only provide a passive scaffold function or only load a single growth factor (such as BMP-2), which cannot simulate this dynamic process. Specifically, how to quickly start vascularization in the early stage of repair to transport "troops" and "provisions" for subsequent repair, and continuously release calcium, phosphorus and other osteogenic signals and zinc ions with anti-inflammatory, pro-osteogenic and potential pro-neuralization functions in the subsequent stage to achieve multiple and synergistic pro-osteogenic effects is a major difficulty currently faced by technology.
[0004] In view of the above bottlenecks, the ideal material should have: 1) early anti-inflammatory and antioxidant functions to create a favorable microenvironment for regeneration; 2) multiple and time-dependent biological activities, i.e. early-stage effective promotion of vascularization and late-stage continuous guidance of osteogenesis and neuralization. This requires the material to integrate multiple active components (such as anti-inflammatory molecules, pro-angiogenic drugs, and bioactive ions) in the design and achieve the programmed function of the material through sophisticated structure control.
[0005] Based on this, the application develops a mineralized fiber network composite bone repair aerogel with early anti-inflammatory and multiple osteogenesis promoting functions. The material is designed and functionally modified through a unique structure, aiming to solve a series of key problems such as early inflammation control, early angiogenesis induction, and subsequent osteogenesis and nerve promotion promotion, and provides a new solution for the regeneration and repair of complex bone defects. SUMMARY
[0006] The purpose of the application is to solve the problems of single function and poor bone repair effect of traditional bone repair materials, and provide a mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple osteogenesis promoting functions and a preparation method thereof.
[0007] The application adopts the following technical solutions: 1) Chitosan fibers are prepared by wet spinning, and are twisted to form fiber bundles; 2) The fiber bundles are woven into fiber nets according to a specific arrangement, and a plurality of fiber nets are fixed in parallel on a pouring mold; the fibers are surface-activated by combining a plasma activation process, and Zn 2+ doped hydroxyapatite coating is formed on the surface thereof by using a hydrothermal method; 3) Alkali-soluble chitosan solution is poured in the pouring mold, and in-situ gelation is realized at high temperature; 4) After dialysis of the gel, thioctic acid molecules are grafted on the surface thereof by combining a surface chemical grafting technology; 5) A soaking process is used to introduce a pro-angiogenic drug into the gel, and the desired composite bone repair aerogel is obtained after freeze-drying.
[0008] Further, the chitosan spinning solution in step 1) is 0.15-0.5 wt% chitosan with a degree of deacetylation of 85 or more and a viscosity-average molecular weight of 10-50 kDa, 2-3.5 wt% chitosan with a degree of deacetylation of 85 or more and a viscosity-average molecular weight of 500-1000 kDa, 1-3 v / v% acetic acid, 0.5-0.75 wt% sodium sulfate, 0.5-1 wt% urea, 0.35-0.5 wt% glycerol, and the rest is deionized water; the formula of the coagulation bath is 40-70 g / L sodium hydroxide, 25-40 v / v% ethanol, 3-7 wt% sodium sulfate, and the rest is deionized water. The process parameters of chitosan wet spinning are as follows: the temperature of the spinning solution is controlled at 25-28℃, the temperature of the coagulation bath is controlled at 18-23℃, the nozzle aperture of the spinning nozzle is 100-150 microns, the draft ratio in the front section of air is 1.1-1.5, the draft ratio in the coagulation bath is 1.5-2.5, and the draft ratio in the air after leaving the coagulation bath is 1.2-2.0; after spinning, the fiber is dialyzed with deionized water, the liquid is changed every 15 min, and the number of liquid changes is controlled at 5-10 times. The above fibers are dried in a vacuum oven, the temperature is 60-75℃, and the drying time is 1-5 h; the dried fibers are twisted to form fiber bundles in different arrangement ways.
[0009] Further, the plasma activation process in step 2) is as follows: the fiber bundle is placed in a cavity with a vacuum degree of 10-50 Pa, a plasma device with a power of 50-120 W and a radio frequency of 12-15 MHz is used, oxygen is used as the process gas, the gas flow is 20-45 sccm, and the treatment time is 30-150 s. The hydrothermal method forms Zn 2+ The process of doped hydroxyapatite coating is as follows: the above fiber bundles are woven into different network structures, 3-5 same fiber networks are arranged in multiple layers in parallel, and are fixed on a specially designed casting mold, the mold is completely immersed in a biomimetic mineralization solution, the reaction container is sealed, the temperature of the mineralization solution is controlled at 35-38℃, and the mineralization time is 24-72 h; the preparation process and formula of the biomimetic mineralization solution are as follows: calcium source and phosphorus source mother liquor are prepared respectively: the calcium source mother liquor contains 130-160 mmol / L calcium nitrate pentahydrate, 2.5-4.5 mmol / L zinc nitrate hexahydrate, and 0.3-0.6 mmol / L sodium citrate dihydrate; the phosphorus source mother liquor contains 75-95 mmol / L diammonium hydrogen phosphate, 0.35-0.6 mmol / L magnesium chloride hexahydrate, and 4.5-5.5 mmol / L sodium bicarbonate. Under vigorous stirring, first adjust the pH of the phosphorus source mother liquor to 9.5, then slowly add the calcium source mother liquor, and finally adjust the pH of the mixed solution to 7.2-7.4 and make up to 1 L.
[0010] Further, the alkali-dissolved chitosan solution formula in step 3) is: 4-6 wt% urea, 1.5-2.5 wt% thiourea, 2-6 wt% chitosan with a deacetylation degree of more than 85 and a viscosity-average molecular weight of 500 kDa-1000 kDa, 4-5.5 wt% lithium hydroxide monohydrate, 0.5-1.0 wt% PEG-400, 0.5-1.0 wt% nanocellulose, and the rest is deionized water. The alkali-dissolving process is as follows: first, chitosan and nanocellulose are stirred and swelled in deionized water for 30-60 min, then other additives are added in turn, and stirring and dissolution are continued for 30-60 min, then it is transferred to a condition of -20--80°C for freezing, then it is transferred to room temperature for 5-10 min to change from a completely frozen state to a partially frozen state, and ice breaking is performed manually or mechanically until it is completely melted; the above operation is repeated 3-6 times to achieve complete dissolution of chitosan. After centrifugal defoaming at 5000-8000 rpm, the alkali-dissolved chitosan solution is cast against the wall in the above pouring mold, and after sealing the mold, it is quickly transferred to a condition of 60-80°C for 4-6 h for gelation treatment.
[0011] Further, the dialysis operation in step 4) is as follows: after demolding treatment of the above gel, a large amount of deionized water is used for dialysis to remove impurities, and the solution is changed every 6 h until the pH of the dialysate is 6.8-7.3. The chemical grafting process of thioctic acid is as follows: a certain volume of 20-30 mM thioctic acid ethanol / DMSO solution is taken and added to the EDC / NHS activation solution, and the activation reaction is carried out at room temperature for 15-30 minutes on a shaker or magnetic stirrer in the dark; the hydrogel is soaked in ice-cold 0.1M MES buffer (pH=5.5) for 15-30 min, and the pretreated chitosan hydrogel is taken out from the MES buffer and the excess liquid on the surface is absorbed with filter paper. The hydrogel is immersed in the above newly prepared EDC / NHS reaction solution containing activated thioctic acid. At room temperature or 4°C, it is placed on a shaker at a low speed of 30-60 rpm for 2-6 h in the dark. The surface of the hydrogel is rinsed several times with a large amount of PBS (pH=7.4) to quickly terminate the coupling reaction, and then it is further soaked in PBS solution for dialysis to remove impurities.
[0012] Further, the step 5) of the blood vessel promoting drug is one or more of VEGF-A, PDGF, Ang-1, tanshinone IIA, astragaloside, ligustrazine and ferulic acid, and the concentration is 10-500 ug / mL. The solution temperature is controlled at 4-10℃, and the immersion time is 30-120 min. After the immersion, the sample is immediately rinsed with deionized water, and then transferred to a-20--80℃ environment for freezing, and then transferred to a condition with a vacuum degree higher than 5 Pa and a temperature lower than-50℃ for freeze-drying for 12-48 h to obtain the required composite bone repair aerogel.
[0013] Compared with the prior art, the present application has the following advantages: 1) Systematic synergy of raw materials and process: In the present application, a double molecular weight chitosan combination strategy is adopted in the selection of raw materials: low molecular weight chitosan (0.15-0.5wt%) as a filler phase, which effectively improves the rheological properties of the spinning solution and promotes the rearrangement of molecular chains during fiber formation; high molecular weight chitosan (2-3.5wt%) as a skeleton phase, which forms a stable three-dimensional network structure through molecular chain entanglement. In the coagulation bath formula, sodium hydroxide (40-70g / L) provides an alkaline environment to promote the solidification of chitosan, ethanol (25-40v / v%) controls the fiber morphology by regulating the solvent exchange rate, and sodium sulfate (3-7wt%) promotes molecular chain aggregation through salting-out effect to form a dense fiber structure. In the process design, the basic fiber network is constructed by wet spinning, the surface reactivity is enhanced by plasma activation, the bioactive coating is introduced by hydrothermal mineralization, the antioxidant function is given by chemical grafting, and the blood vessel promoting ability is achieved by drug loading. Each process link is closely connected: the fiber network formed by wet spinning provides a carrier for subsequent functional modification, the active sites generated by plasma activation promote the combination of mineralized coating, and the micro-nano structure constructed by hydrothermal mineralization increases the specific surface area, which creates favorable conditions for chemical grafting and drug loading. This systematic cooperation of raw materials and process ensures the integrity and coordination of the material from macrostructure to microfunction.
[0014] 2) Deep coupling between multi-level structure design and biological function: The invention constructs a four-level synergistic structure system, and the structures at each level form a close functional complementation and synergistic relationship. The first level is the fiber network structure, which is formed by wet spinning and twisting and weaving processes. It not only provides mechanical support, but also has a specific orientation. Its unique channel structure also provides a channel for cell migration and nutrient transport. The second level is the mineralized coating, which is pre-treated by plasma activation to enhance the bonding strength. The zinc-doped hydroxyapatite coating not only retains the bone conductivity of traditional hydroxyapatite, but also imparts antibacterial and nerve differentiation promoting functions through the introduction of zinc ions. The third level is the gel matrix, which is filled with alkali-soluble chitosan solution in the gap between the fiber network. Its microporous structure provides storage space for drug molecules and creates a suitable cell microenvironment. The fourth level is functional molecules, which are grafted on the surface and loaded inside the material to exert specific biological functions at different locations. The synergistic effect between the structures at each level is as follows: the fiber network provides mechanical support to ensure the structural integrity of the material after implantation; the mineralized coating enhances the biological activity and promotes the integration of the material-tissue interface; the gel matrix regulates drug release to achieve time-sequential expression of functions; and the functional molecules precisely regulate biological responses to optimize the repair microenvironment. The organic combination of this multi-level structure enables the material to meet the multiple requirements of mechanical properties, biological activity, and functional regulation during bone repair.
[0015] 3) Precise regulation mechanism of time-sequential function release: Through careful material design and process control, the invention achieves time-sequential regulation of function release. At the initial stage of implantation, the surface-grafted lipoic acid molecules quickly scavenge reactive oxygen species through their double-sulfur five-membered ring structure, inhibiting the expression of inflammatory factors and creating a stable microenvironment for the subsequent repair process. The function exertion at this stage mainly depends on the stable covalent bond formed by chemical grafting, ensuring that lipoic acid molecules continuously exert their effects during the peak of inflammation. In the middle stage of repair, the pro-angiogenic drugs in the gel network are released slowly through molecular diffusion and matrix degradation, promoting the migration of vascular endothelial cells and the formation of lumens. The function regulation at this stage benefits from the special network structure of alkali-soluble chitosan gel, which has a degradation rate matching the process of angiogenesis, ensuring that the drugs are continuously effective during the critical repair period. In the late stage of repair, the zinc-doped hydroxyapatite coating continuously releases calcium and phosphorus ions and zinc ions through ion exchange mechanism. Calcium and phosphorus ions promote osteoblast differentiation and matrix mineralization by providing mineral components required for bone formation; zinc ions promote osteogenic differentiation and nerve ingrowth by regulating multiple cell signaling pathways. This time-sequential design based on different release kinetics makes the function expression of the material highly consistent with the natural process of bone repair.
[0016] 4) Process innovation and interface breakthrough: In this invention, a close collaborative relationship is formed between each process link. The wet spinning process realizes the controllable adjustment of fiber morphology and structure by precisely controlling the spinning solution composition and coagulation bath conditions. Among them, the concentration of acetic acid (1-3 v / v%) affects the stretching degree of chitosan molecular chain, urea (0.5-1 wt%) and glycerol (0.35-0.5 wt%) improve the stability of the spinning solution, and the three-stage drawing process regulates the fiber orientation and crystallinity. The plasma activation process introduces active groups and increases the surface roughness of the fiber by optimizing the process parameters (vacuum degree 10-50 Pa, power 50-120 W), providing more nucleation sites for the subsequent mineralization process. The innovation of this step is to realize surface modification through gas phase treatment, avoiding the possible structural damage of the fiber caused by liquid phase treatment. The hydrothermal mineralization process realizes the controllable growth of the functional coating by precisely adjusting the composition of the mineralization solution and the reaction conditions. The new formula of calcium and phosphorus mother liquor ensures the normal growth of crystals, the introduction of zinc ions changes the physicochemical properties of the coating through lattice doping, the addition of magnesium ions regulates the crystal morphology, and sodium citrate inhibits the excessive growth of crystals. This multi-component collaborative mineralization system makes the coating have good bioactivity and suitable degradation performance. The alkali-soluble chitosan process successfully solves the dissolution problem of high-concentration chitosan in alkaline conditions through a urea-thiourea-lithium hydroxide composite solvent system combined with freeze-ice breaking cycle treatment. The addition of nanocellulose enhances the mechanical properties of the gel, and PEG-400 improves the stability of the system, finally forming a gel matrix with ideal three-dimensional network structure.
[0017] 5) Multi-functional synergistic mechanism: This invention realizes the optimization and improvement of bone repair effect through the synergistic cooperation of multiple functional mechanisms. In the anti-inflammatory mechanism, thioctic acid inhibits the activation of the NF-κB signaling pathway by scavenging reactive oxygen species, and zinc ions regulate the expression of inflammatory factors, both of which synergistically control the inflammatory response after implantation. In the pro-angiogenesis mechanism, the multi-level pore structure of the material provides physical space for the migration of vascular endothelial cells, the pro-angiogenesis drug promotes angiogenesis by activating the VEGF signaling pathway, and zinc ions improve the function of the newly formed blood vessels by enhancing their stability, all of which synergistically promote the formation of functional vascular networks. In the osteogenesis mechanism, the mechanical stimulation of the fiber network promotes the differentiation of osteoblasts, calcium and phosphorus ions provide the necessary minerals for bone formation, and zinc ions regulate the expression of osteogenesis-related genes, all of which synergistically accelerate the deposition and mineralization of bone matrix. In the neuralization mechanism, zinc ions guide the growth of nerves by promoting the expression of nerve growth factors, and the multi-level pore structure of the material provides a path for the extension of neural synapses, both of which synergistically promote the re-establishment of neural networks.
[0018] 6) Systematic optimization of overall performance: Through systematic material design and process optimization, the invention realizes the overall improvement of the material's overall performance. In terms of mechanical properties, the fiber network provides the main tensile strength, the mineralized coating enhances the surface hardness, and the gel matrix improves the material toughness. The three work together to make the material's mechanical properties match those of natural bone tissue. In terms of biological function, early anti-inflammatory function prevents the wrapping of fibrotic tissue, medium-term vascular function ensures nutrition supply, and late osteogenic function promotes tissue regeneration. The functions of each stage are orderly linked to ensure the smooth progress of the repair process. In terms of degradation performance, the degradation rates of each component are consistent with the progress of tissue regeneration: the gel matrix degrades to provide space for cells during vascularization, the mineralized coating slowly degrades to continuously release active ions during osteogenesis, and the fiber network gradually degrades to complete its mission during the later stages of repair. This all-round performance optimization enables the material to effectively cope with various challenges in bone repair, providing a new solution for the repair of complex bone defects.
[0019] 7) Innovative process of fiber surface activation and mineralization synergy: The invention innovatively combines plasma activation and hydrothermal mineralization processes to form a unique surface functionalization system. The plasma activation process modifies the fiber surface under specific parameters (vacuum 10-50 Pa, power 50-120 W, oxygen flow 20-45 sccm). Through physical bombardment and chemical oxidation, it introduces active groups such as carboxyl and hydroxyl groups onto the fiber surface, significantly increasing the surface roughness and providing sufficient nucleation sites for the subsequent mineralization process. The hydrothermal mineralization process controls the temperature (35-38°C) and time parameters (24-72h) to generate a zinc-doped hydroxyapatite coating on the activated fiber surface in situ by adjusting the composition of the mineralization solution. The synergy of surface activation and mineralization not only significantly enhances the bonding strength between the coating and the fiber substrate, but more importantly, it realizes the precise regulation of the material's biological activity by adjusting the composition and structure of the coating.
[0020] 8) Innovative preparation process of alkali-soluble chitosan gel system: The invention develops a unique preparation process of alkali-soluble chitosan gel, breaking through the limitations of traditional dissolution methods. By using a urea (4-6 wt%) -thiourea (1.5-2.5 wt%) -lithium hydroxide (4-5.5 wt%) composite solvent system, combined with freeze-ice breaking cycle processing (3-6 times), the complete dissolution of high-concentration chitosan (2-6 wt%) under alkaline conditions is successfully achieved. The innovative mechanism of this process lies in: urea-thiourea destroys the hydrogen bond network between chitosan molecular chains by forming inclusion compounds, lithium hydroxide provides a strong alkaline environment to promote the stretching of chitosan molecular chains, and freeze-ice breaking cycle further destroys the molecular aggregation structure through the formation and melting process of ice crystals. The introduction of nanocellulose (0.5-1.0 wt%) in the formula forms an interpenetrating network with chitosan molecular chains to enhance the mechanical properties of the gel, and PEG-400 (0.5-1.0 wt%) prevents the re-aggregation of molecular chains through steric hindrance effect. Finally, through high-temperature gelation treatment (60-80℃, 4-6h), a stable three-dimensional network structure is formed, providing an ideal carrier for cell growth and drug loading.
[0021] 9) Innovative design of time-dependent drug loading and release system: The invention constructs a drug loading and release system with spatiotemporal control function. In the drug loading stage, precise positioning of functional molecules is achieved through a step-by-step process: first, the thioctic acid molecule (20-30 mM) is covalently grafted to the material surface through EDC / NHS-mediated coupling reaction, forming a stable anti-inflammatory functional layer; then, the pro-angiogenic drug (10-500 μg / mL) is loaded into the gel network through low-temperature immersion process (4-10℃, 30-120 min), utilizing temperature regulation to control the diffusion rate and distribution uniformity of drug molecules. In terms of release control, the system adopts a multi-mechanism collaborative control strategy: the surface-grafted thioctic acid molecules achieve sustained release through the stable covalent bond, ensuring continuous action during the key period of inflammation; the internally loaded pro-angiogenic drug achieves controlled release through diffusion and degradation mechanisms, with its release kinetics matching the angiogenesis process; the zinc-doped hydroxyapatite coating slowly releases active ions through ion exchange mechanism, providing continuous osteoinductive signals in the later repair period. This multi-level drug loading and release design ensures that the material can provide appropriate bioactive signals throughout the entire repair period. BRIEF DESCRIPTION OF DRAWINGS
[0022] Figure 1 Preparation flowchart of mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions.
[0023] Figure 2Examples of the weaving method of the fiber network in the mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions (including but not limited to the fiber weaving method shown in the figure); Figure 3 Effects of the mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions on the proliferation of BMSCs (the control group is a completely dialyzed alkali-dissolved chitosan hydrogel); Figure 4 Repair effects of the mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions on the rat skull defect model (A corresponds to Example 3, and B corresponds to Example 1). DETAILED DESCRIPTION
[0024] The technical solutions of the present application will be further described in detail below in combination with the drawings and specific examples. The deacetylation degrees of the low molecular weight chitosan and the high molecular weight chitosan used in the examples are both above 85.
[0025] Example 1 1) Chitosan fiber was prepared by wet spinning: a spinning solution containing 0.3wt% low molecular weight chitosan (viscosity average molecular weight 30kDa) and 2.5wt% high molecular weight chitosan (viscosity average molecular weight 800kDa) was prepared with deionized water as the solvent, 2v / v% acetic acid, 0.6wt% sodium sulfate, 0.8wt% urea, and 0.4wt% glycerol were added. The coagulation bath was 50g / L sodium hydroxide, 30v / v% ethanol, and 5wt% sodium sulfate aqueous solution. The temperature of the spinning solution was controlled at 26℃, the temperature of the coagulation bath was controlled at 20℃, the nozzle aperture was 120μm, and the three-stage drawing ratio was 1.3, 2.0, and 1.6, respectively. After spinning, the fibers were dialyzed and dried at 60℃ for 3h, and then 3 fibers were taken out each time to form a fiber bundle by twisting. The average diameter of the obtained fibers was 125±8μm, and the tensile strength reached 185±12MPa.
[0026] 2) Fiber surface modification treatment: the fiber bundle was woven into a fiber network, and three layers of parallel arrangement were fixed in a mold and placed in a plasma device for plasma activation treatment, with a vacuum degree of 30Pa, a power of 80W, a radio frequency of 12MHz, an oxygen flow rate of 30sccm, and a treatment time of 90s. Subsequently, hydrothermal mineralization was performed by completely immersing the mold in a biomimetic mineralization solution; the mineralization solution contained a calcium source mother liquor (145mmol / L calcium nitrate, 3.5mmol / L zinc nitrate, and 0.45mmol / L sodium citrate) and a phosphorus source mother liquor (85mmol / L diammonium hydrogen phosphate, 0.5mmol / L magnesium chloride, and 5mmol / L sodium bicarbonate), and the mineralization was performed at 37℃ for 48h, and finally the pH was adjusted to 7.3.
[0027] 3) Pouring the gel matrix: prepare the alkali solution of chitosan, containing 5wt% urea, 2wt% thiourea, 4wt% chitosan with a molecular weight of 750kDa, 5wt% lithium hydroxide, 0.8wt% PEG-400, 0.8wt% nanocellulose. First, chitosan and nanocellulose are swelled in deionized water for 45min, then other components are added and dissolved for 45min, and then repeated freezing at-40℃ and ice breaking at room temperature for 4 times. After centrifugation at 6000r / min to remove bubbles, pour into the mold and gel at 70℃ for 5h.
[0028] 4) Surface chemical grafting: after demolding, dialysis to pH close to 7. Take 25mM lipoic acid ethanol / DMSO solution, activate with EDC / NHS for 20min, first equilibrate the sample in pH=5.5 MES buffer for 15min, then take it out and put it in the activated lipoic acid ethanol / DMSO solution at 4℃ for 4h, and finally wash with PBS to terminate the reaction.
[0029] 5) Drug loading and molding: immerse in a solution containing 200μg / mL VEGF-A and astragaloside, control the temperature at 6℃, and the time for 60min. After taking out and washing with deionized water, pre-freeze at-40℃, and then freeze-dry at-50℃, 3Pa for 24h to obtain the final product.
[0030] Take 500mg of the obtained material, add 1mL of sterile medium for extraction, and place it in a 37℃, 5% CO2 cell incubator for 24h. After centrifugation and filtration, the filtrate is obtained as the material extract.
[0031] After co-culturing the material extract with bone marrow mesenchymal stem cells, CCK-8 detection showed that the relative survival rate of cells reached 92%. In the rat skull defect model, H&E staining of tissue sections showed a significant reduction in the number of inflammatory cells after 1 week of implantation, and CD31 immunofluorescence staining showed that the density of newly formed blood vessels reached (28.7±3.2) per mm 2 after 4 weeks. Micro-CT showed that the new bone volume fraction (BV / TV) reached (35.2±2.8)% after 8 weeks, and β-III tubulin staining showed obvious nerve fiber ingrowth.
[0032] Example 2 1) Chitosan fiber prepared by wet spinning: Deionized water was used as solvent to prepare the spinning solution containing 0.15wt% low molecular weight chitosan (viscosity average molecular weight 30 kDa) and 3.5wt% high molecular weight chitosan (viscosity average molecular weight 800 kDa), with the addition of 2v / v% acetic acid, 0.6wt% sodium sulfate, 0.8wt% urea, and 0.4wt% glycerol. The coagulation bath was 50g / L sodium hydroxide, 30v / v% ethanol, and 5wt% sodium sulfate aqueous solution. The temperature of the spinning solution was controlled at 26℃, the temperature of the coagulation bath was controlled at 20℃, the nozzle aperture was 120μm, and the three-stage drawing ratio was 1.3, 2.0, and 1.6, respectively. After spinning, the fibers were dialyzed, vacuum dried at 60℃ for 3h, and twisted into fiber bundles by taking 3 fibers each time. The average diameter of the obtained fibers was 118±6μm, and the tensile strength was increased to 215±15MPa.
[0033] 2) Surface modification of the fibers: The fiber bundles were woven into a fiber web and arranged in three layers in parallel and fixed in a mold. Plasma activation treatment was performed in a plasma device with the following parameters: vacuum degree 30Pa, power 80W, radio frequency 12MHz, oxygen flow rate 30sccm, and treatment time 90s. Subsequently, hydrothermal mineralization was performed by completely immersing the mold in a biomimetic mineralization solution. The mineralization solution contained a calcium source stock solution (145mmol / L calcium nitrate, 3.5mmol / L zinc nitrate, and 0.45mmol / L sodium citrate) and a phosphorus source stock solution (85mmol / L diammonium hydrogen phosphate, 0.5mmol / L magnesium chloride, and 5mmol / L sodium bicarbonate), and the mineralization was carried out at 37℃ for 48h, with the final pH adjusted to 7.3.
[0034] 3) Casting of the gel matrix: An alkali-soluble chitosan solution was prepared containing 5wt% urea, 2wt% thiourea, 4wt% chitosan with a molecular weight of 750kDa, 5wt% lithium hydroxide, 0.8wt% PEG-400, and 0.8wt% nanocellulose. The chitosan and nanocellulose were first swelled in deionized water for 45min, and then the other components were added and dissolved for 45min. After being frozen at -40℃, the ice was broken at room temperature, and the process was repeated 4 times. After centrifugation at 6000rpm / min to remove bubbles, the solution was cast into the mold and gelled at 70℃ for 5h.
[0035] 4) Surface chemical grafting: After demolding, dialysis was performed to adjust the pH to approximately 7. A 25mM lipoic acid ethanol / DMSO solution was activated with EDC / NHS for 20min. The sample was first equilibrated in a pH=5.5 MES buffer for 15min, then removed and added to the activated lipoic acid ethanol / DMSO solution for reaction at 4℃ for 4h. Finally, the reaction was terminated by washing with PBS.
[0036] 5) Drug loading and molding: Immersed in a solution containing 200 μg / mL VEGF-A and astragaloside, the temperature was controlled at 6℃ for 60 min. After being taken out and rinsed with deionized water, pre-frozen at -40℃, and then freeze-dried at -50℃ for 24 h under 3 Pa, the final product was obtained.
[0037] After the material extract solution was co-cultured with bone marrow mesenchymal stem cells, CCK-8 detection showed that the relative survival rate of the cells was 89%. In the rat calvarial defect model, the inflammatory reaction control effect after 1 week of implantation was comparable to that of Example 1, the density of newly formed blood vessels was (26.5±2.8) per mm 2 after 4 weeks, and the new bone volume fraction (BV / TV) was (33.1±2.6)% after 8 weeks. β-III tubulin staining showed that the degree of nerve growth was similar to that of Example 1. Compared with Example 1, increasing the proportion of high molecular weight chitosan slightly reduced the fiber diameter, significantly improved the tensile strength, but may have affected the pore structure and drug release characteristics of the material, resulting in a slight decrease in the effects of angiogenesis and osteogenesis.
[0038] Example 3 1) Chitosan fiber was prepared by wet spinning: a spinning solution containing 0.3wt% low molecular weight chitosan (viscosity average molecular weight 30 kDa) and 2.5wt% high molecular weight chitosan (viscosity average molecular weight 800 kDa) was prepared using deionized water as the solvent, 2v / v% acetic acid, 0.6wt% sodium sulfate, 0.8wt% urea, and 0.4wt% glycerol were added. The coagulation bath was 50g / L sodium hydroxide, 30v / v% ethanol, and 5wt% sodium sulfate aqueous solution. The temperature of the spinning solution was controlled at 26℃, the temperature of the coagulation bath was controlled at 20℃, the nozzle aperture was 120μm, and the three-stage drawing ratio was 1.3, 2.0, and 1.6, respectively. After spinning, the fibers were dialyzed, vacuum dried at 60℃ for 3h, and twisted to form a fiber bundle by taking 3 fibers each time. The average diameter of the obtained fibers was 125±8μm, and the tensile strength was 185±12MPa.
[0039] 2) Fiber surface modification treatment: the fiber bundle was woven into a fiber mesh, which was arranged in three layers in parallel and fixed in a mold, and then subjected to plasma activation treatment in a plasma device with the following parameters: vacuum degree 30Pa, power 80W, radio frequency 12MHz, oxygen flow rate 30sccm, and treatment time 90s. Subsequently, hydrothermal mineralization was performed by completely immersing the mold in a biomimetic mineralization solution containing a calcium source stock solution (145mmol / L calcium nitrate, 2.5mmol / L zinc nitrate, 0.45mmol / L sodium citrate) and a phosphorus source stock solution (85mmol / L diammonium hydrogen phosphate, 0.5mmol / L magnesium chloride, 5mmol / L sodium bicarbonate) at 37℃ for 24h, and finally adjusting the pH to 7.3.
[0040] 3) Pouring the gel matrix: prepare the alkali solution of chitosan, containing 5wt% urea, 2wt% thiourea, 4wt% chitosan with a molecular weight of 750kDa, 5wt% lithium hydroxide, 0.8wt% PEG-400, and 0.8wt% nanocellulose. First, chitosan and nanocellulose are swelled in deionized water for 45min, then other components are added and dissolved for 45min, and then repeated freezing at-40℃ and ice breaking at room temperature for 4 times. After centrifugation at 6000rpm to remove bubbles, pour into the mold and gel at 70℃ for 5h.
[0041] 4) Surface chemical grafting: after demolding, dialysis to pH close to 7. Take 25mM lipoic acid ethanol / DMSO solution, activate with EDC / NHS for 20min, first equilibrate the sample in pH=5.5 MES buffer for 15min, then take it out and put it in the activated lipoic acid ethanol / DMSO solution at 4℃ for 4h, and finally wash with PBS to terminate the reaction.
[0042] 5) Drug loading and molding: immerse in a solution containing 200μg / mL VEGF-A and astragaloside, control the temperature at 6℃, and the time for 60min. After taking out and rinsing with deionized water, pre-freeze at-40℃, and then freeze-dry at-50℃, 3Pa for 24h to obtain the final product.
[0043] After co-culturing the material leaching solution with bone marrow mesenchymal stem cells, CCK-8 detection showed that the relative survival rate of cells was 90%. In the rat skull defect model, the inflammatory reaction was well controlled after 1 week of implantation, the density of new blood vessels was (25.8±2.9) / mm 2 after 4 weeks, and the new bone volume fraction (BV / TV) was (32.5±2.7)% after 8 weeks. β-III tubulin staining showed that the degree of nerve growth was lower than that of Example 1. Compared with Example 1, reducing the zinc doping concentration and shortening the mineralization time affected the bioactivity and ion release characteristics of the coating, resulting in weakened nerve and osteogenesis effects. The diameter and mechanical properties of the fibers remained consistent with Example 1.
[0044] Example 4 1) Chitosan fiber prepared by wet spinning: Deionized water was used as solvent to prepare the spinning solution containing 0.3wt% low molecular weight chitosan (viscosity average molecular weight 30 kDa) and 2.5wt% high molecular weight chitosan (viscosity average molecular weight 800 kDa), 2v / v% acetic acid, 0.6wt% sodium sulfate, 0.8wt% urea, 0.4wt% glycerol were added. The coagulation bath was 50g / L sodium hydroxide, 30v / v% ethanol, 5wt% sodium sulfate aqueous solution. The temperature of the spinning solution was controlled at 26℃, the temperature of the coagulation bath was controlled at 20℃, the nozzle aperture was 120μm, the three-stage drawing ratio was 1.3, 2.0, 1.6 respectively. After spinning, the fibers were dialyzed, vacuum dried at 60℃ for 3h, and twisted into fiber bundles by taking 3 fibers each time. The average diameter of the obtained fibers was 125±8μm, and the tensile strength was 185±12MPa.
[0045] 2) Surface modification of the fibers: The fiber bundles were woven into a fiber web and arranged in three layers in parallel and fixed in a mold. The mold was placed in a plasma device for plasma activation treatment with a vacuum degree of 30Pa, a power of 80W, a radio frequency of 12MHz, an oxygen flow of 30sccm, and a treatment time of 90s. Subsequently, hydrothermal mineralization was performed by completely immersing the mold in a biomimetic mineralization solution. The mineralization solution contained a calcium source stock solution (145mmol / L calcium nitrate, 3.5mmol / L zinc nitrate, 0.45mmol / L sodium citrate) and a phosphorus source stock solution (85mmol / L diammonium hydrogen phosphate, 0.5mmol / L magnesium chloride, 5mmol / L sodium bicarbonate), and the mineralization was carried out at 37℃ for 48h, with the final pH adjusted to 7.3.
[0046] 3) Casting of the gel matrix: An alkali-soluble chitosan solution was prepared containing 5wt% urea, 2wt% thiourea, 3wt% chitosan with a molecular weight of 750kDa, 5wt% lithium hydroxide, 0.8wt% PEG-400, and 0.8wt% nanocellulose. The chitosan and nanocellulose were first swelled in deionized water for 45min, and then the other components were added and dissolved for 45min. After being frozen at -40℃, the ice was broken at room temperature, and the process was repeated 4 times. After centrifugation at 6000rpm / min to remove bubbles, the solution was cast into a mold and gelled at 70℃ for 5h.
[0047] 4) Surface chemical grafting: After demolding, dialysis was performed to adjust the pH to approximately 7. A 25mM lipoic acid ethanol / DMSO solution was activated with EDC / NHS for 20min. The sample was first equilibrated in a pH=5.5 MES buffer for 15min, then taken out and placed in the activated lipoic acid ethanol / DMSO solution for 4h at 4℃, and finally washed with PBS to terminate the reaction.
[0048] 5) Drug loading and molding: soaked in a solution containing 200 μg / mL VEGF-A and astragalus glycosides, the temperature was controlled at 6℃ for 60 min. After being taken out and rinsed with deionized water, it was pre-frozen at -40℃, and then freeze-dried at -50℃ and 3 Pa for 24 h to obtain the final product.
[0049] After the material extract solution was co-cultured with bone marrow mesenchymal stem cells, CCK-8 detection showed that the relative survival rate of the cells was 94%. In the rat skull defect model, the inflammatory response was best controlled after 1 week of implantation, and the density of new blood vessels was (30.2±3.1) per mm 2 at 4 weeks, and the new bone volume fraction (BV / TV) was (34.8±2.9)% at 8 weeks. β-III tubulin staining showed that the degree of nerve growth was comparable to that of Example 1. Compared with Example 1, reducing the concentration of chitosan improved the pore structure and degradation performance of the material, promoted faster vascularization and tissue ingrowth, while maintaining good mechanical support function. The diameter and strength parameters of the fibers were the same as those of Example 1.
[0050] Example 5 1) Chitosan fibers were prepared by wet spinning: deionized water was used as the solvent to prepare a spinning solution containing 0.3wt% low molecular weight chitosan (viscosity average molecular weight 30 kDa) and 2.5wt% high molecular weight chitosan (viscosity average molecular weight 800 kDa), with the addition of 2v / v% acetic acid, 0.6wt% sodium sulfate, 0.8wt% urea, and 0.4wt% glycerol. The coagulation bath was 50g / L sodium hydroxide, 30v / v% ethanol, and 5wt% sodium sulfate aqueous solution. The spinning solution temperature was controlled at 26℃, the coagulation bath temperature was controlled at 20℃, the nozzle aperture was 120μm, and the three-stage drawing ratio was 1.3, 2.0, and 1.6, respectively. After spinning, the fibers were dialyzed, vacuum dried at 60℃ for 3h, and twisted into a fiber bundle by taking 3 fibers at a time. The average diameter of the obtained fibers was 125±8μm, and the tensile strength was 185±12MPa.
[0051] 2) Fiber surface modification treatment: the fiber bundle was woven into a fiber mesh, which was arranged in three layers in parallel and fixed in a mold, and then subjected to plasma activation treatment in a plasma device with the following parameters: vacuum degree 30Pa, power 80W, radio frequency 12MHz, oxygen flow rate 30sccm, and treatment time 90s. Subsequently, hydrothermal mineralization was performed by completely immersing the mold in a biomimetic mineralization solution; the mineralization solution contained a calcium source stock solution (145mmol / L calcium nitrate, 3.5mmol / L zinc nitrate, 0.45mmol / L sodium citrate) and a phosphorus source stock solution (85mmol / L diammonium hydrogen phosphate, 0.5mmol / L magnesium chloride, 5mmol / L sodium bicarbonate), and the mineralization was carried out at 37℃ for 48h, with the final pH adjusted to 7.3.
[0052] 3) Gel casting: Dissolve chitosan and nanocellulose in deionized water for 45 min, then add other components and dissolve for another 45 min. Freeze at -40℃ and thaw at room temperature for 4 times. Centrifuge at 6000 rpm to remove bubbles, and then cast into the mold. Gelation at 70℃ for 5h.
[0053] 4) Surface chemical grafting: After demolding, dialysis to pH close to 7. This example omits the lipoic acid grafting step and only uses MES buffer for equilibration treatment under the same conditions.
[0054] 5) Drug loading and molding: Soak in a solution containing 200μg / mL VEGF-A and astragalus glycosides, control the temperature at 6℃, and the time for 60 min. After taking out and rinsing with deionized water, pre-freeze at -40℃, and then freeze-dry at -50℃, 3Pa for 24h to obtain the final product.
[0055] After co-culturing the material extract with bone marrow mesenchymal stem cells, CCK-8 detection showed that the relative survival rate of cells was 88%. In the rat calvarial defect model, H&E staining of tissue sections showed obvious inflammatory cell infiltration 1 week after implantation, and the degree of inflammatory reaction was significantly higher than that of other examples. CD31 immunofluorescence staining showed that the density of new blood vessels was (22.4±2.5) / mm 2 at 4 weeks, and Micro-CT showed that the new bone volume fraction (BV / TV) was (28.7±2.4)% at 8 weeks. β-III tubulin staining showed that the growth of nerve fibers was limited. Compared with Example 1, the diameter and mechanical properties of the fibers were the same, but the lack of surface anti-inflammatory molecule grafting led to insufficient control of early inflammation, which in turn affected the subsequent vascularization process and bone regeneration effect, proving the key role of lipoic acid grafting in the early stage of inflammation regulation.
Claims
1. A method for preparing a mineralized fibrous network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions, characterized in that: The method comprises the following steps: 1) preparing chitosan fibers by wet spinning and twisting the fibers to form fiber bundles; 2) weaving the fiber bundles into fiber webs, fixing multiple fiber webs in parallel in a pouring mold; combining a plasma activation process to perform surface activation treatment on the fibers, and then using a hydrothermal method to form ZnO on the surfaces of the fibers 2+ Doped hydroxyapatite coating 3) pouring alkali-dissolved chitosan solution into the pouring mold to perform in-situ gelation; 4) after dialysis of the gel, grafting thioctic acid molecules on the surface of the gel by surface chemical grafting technology; 5) introducing a pro-angiogenic drug into the gel by using an impregnation process, and obtaining the mineralized fiber network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions after freeze-drying.
2. The preparation method of the mineralized fiber network composite bone repair aerogel material with both early anti-inflammatory and multiple osteogenic functions as described in claim 1, characterized in that: The wet spinning in step 1) uses a chitosan spinning solution, which is 0.15-0.5 wt% chitosan with a deacetylation degree of more than 85 and a viscosity average molecular weight of 10-50 kDa, 2-3.5 wt% chitosan with a deacetylation degree of more than 85 and a viscosity average molecular weight of 500-1000 kDa, 1-3 v / v% acetic acid, 0.5-0.75 wt% sodium sulfate, 0.5-1 wt% urea, 0.35-0.5 wt% glycerol, and the rest is deionized water; the coagulation bath used for wet spinning has a formula of 40-70 g / L sodium hydroxide, 25-40 v / v% ethanol, 3-7 wt% sodium sulfate, and the rest is deionized water.
3. The preparation method of the mineralized fiber network composite bone repair aerogel material with both early anti-inflammatory and multiple bone-promoting functions as described in claim 1, characterized in that: The process parameters of the wet spinning in step 1) are as follows: the temperature of the spinning solution is controlled at 25-28℃, the temperature of the coagulation bath is controlled at 18-23℃, the nozzle aperture of the spinning head is 100-150 microns, the draft ratio in the front air is 1.1-1.5, the draft ratio in the coagulation bath is 1.5-2.5, and the draft ratio in the air after leaving the coagulation bath is 1.2-2.0; after spinning, the fibers are dialyzed with deionized water; the obtained fibers are dried in a vacuum oven at a temperature of 60-75℃ for 1-5 h; and 2-5 fibers are taken each time to form fiber bundles.
4. The preparation method of the mineralized fiber network composite bone repair aerogel material with both early anti-inflammatory and multiple osteogenic functions as described in claim 1, characterized in that: The plasma activation process in step 2) is as follows: the sample is placed in a cavity with a vacuum degree of 10-50 Pa, a plasma device with a power of 50-120 W and a radio frequency of 12-15 MHz is used, oxygen is used as the process gas, the gas flow is 20-45 sccm, and the treatment time is 30-150 s.
5. The method for preparing the mineralized fiber network composite bone repair aerogel material with both early anti-inflammatory and multiple osteogenic functions as described in claim 1, characterized in that: The hydrothermal method in step 2) is as follows: the sample is completely immersed in the biomimetic mineralization solution, and the reaction container is sealed, the temperature of the mineralization solution is controlled at 35-38℃, and the mineralization time is 24-72 h; the biomimetic mineralization solution contains a calcium source mother liquor and a phosphorus source mother liquor: the calcium source mother liquor contains 130-160 mmol / L calcium nitrate pentahydrate, 2.5-4.5 mmol / L zinc nitrate hexahydrate, and 0.3-0.6 mmol / L sodium citrate dihydrate; the phosphorus source mother liquor contains 75-95 mmol / L diammonium hydrogen phosphate, 0.35-0.6 mmol / L magnesium chloride hexahydrate, and 4.5-5.5 mmol / L sodium bicarbonate. Under vigorous stirring, the pH of the phosphorus source mother liquor is adjusted to 9.5, the calcium source mother liquor is slowly added, and finally the pH of the mixed solution is accurately adjusted to 7.2-7.4 and the volume is made up to 1 L.
6. The method of claim 1, wherein the method of preparing the mineralized fibrous network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions is characterized by: The formula of the alkali-dissolved chitosan solution in step 3) is: 4-6 wt% urea, 1.5-2.5 wt% thiourea, 2-6 wt% chitosan with a degree of deacetylation of more than 85 and a viscosity-average molecular weight of 500 kDa-1000 kDa, 4-5.5 wt% lithium hydroxide monohydrate, 0.5-1.0 wt% PEG-400, 0.5-1.0 wt% nanocellulose, and the rest is deionized water; the preparation method comprises the following steps: first, chitosan and nanocellulose are stirred and swelled in deionized water for 30-60 min, then other components are added in sequence, and stirring and dissolution are continued for 30-60 min, then it is transferred to a condition of-20--80℃ for freezing, then it is transferred to room temperature for 5-10 min to change from a completely frozen state to a partially frozen state, and ice breaking is performed manually or mechanically until it is completely melted; the above operation is repeated 3-6 times to achieve complete dissolution of chitosan; after centrifugal defoaming at 5000-8000 rpm, the alkali-dissolved chitosan solution is cast against the wall in the casting mold, the mold is sealed, and then it is quickly transferred to a condition of 60-80℃ for 4-6 h for gelation treatment.
7. The method of claim 1, wherein the method is characterized by: The dialysis in step 4) is specifically: after the obtained gel is demolded, deionized water is used for dialysis to remove impurities, the solution is changed every 6 h until the pH of the dialysate is 6.8-7.
3.
8. The method of claim 1, wherein the method of preparing the mineralized fibrous network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions is characterized by: The grafted lipoic acid molecules in step 4) are specifically: the obtained gel is soaked in 0.1M MES buffer solution with a pH of 5.5 for 15-30 min, then it is taken out and immersed in a newly prepared EDC / NHS reaction solution containing activated lipoic acid, and it is placed on a shaker for low-speed (30-60 rpm) light-avoiding reaction for 2-6 h, then it is rinsed on the surface several times with PBS with a pH of 7.4 to quickly terminate the coupling reaction, and then it is continuously soaked in PBS solution for dialysis to remove impurities. The preparation method of the EDC / NHS reaction solution containing activated lipoic acid is: 20-30 mM lipoic acid ethanol / DMSO solution is taken and added to EDC / NHS activation solution, and light-avoiding activation reaction is carried out on a shaker or a magnetic stirrer at room temperature for 15-30 min.
9. The method of claim 1, wherein the method of preparing the mineralized fibrous network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions is characterized by: The pro-angiogenic drug in step 5) is one or more of VEGF-A, PDGF, Ang-1, tanshinone IIA, astragaloside, ligustrazine and ferulic acid, the concentration of the pro-angiogenic drug solution is 10-500 ug / mL during the impregnation, the temperature control is 4-10℃, and the impregnation time is 30-120 min; after the impregnation is completed, deionized water is used for rinsing, then it is transferred to a-20--80℃ environment for freezing, and then it is transferred to a condition of a vacuum degree higher than 5 Pa and a temperature lower than-50℃ for freeze-drying for 12-48 h.
10. A mineralized fibrous network composite bone repair aerogel material with early anti-inflammatory and multiple pro-osteogenic functions, characterized in that, The method is prepared by any one of claims 1-9.
